Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,322 papers from all fields of science
Search
Sign In
Create Free Account
Oxybutynin chloride 5 MG Oral Tablet
Known as:
OXYBUTYNIN CHLORIDE 5 mg ORAL TABLET [Oxybutynin Chloride]
, OXYBUTYNIN CL 5MG TAB [VA Product]
, OXYBUTYNIN CHLORIDE 5MG TAB UD
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
21 relations
Broader (2)
ANTISPASMODICS,URINARY
oxybutynin
Aluminum Oxide
Brilliant blue FCF
CALCIUM STEARATE
Drug Allergy
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Parallel achiral-chiral determination of oxybutynin, N-desethyl oxybutynin and their enantiomers in human plasma by LC-MS/MS to support a bioequivalence trial.
Primal Sharma
,
Daxesh P. Patel
,
Mallika Sanyal
,
S. Guttikar
,
P. Shrivastav
Journal of Pharmaceutical and Biomedical Analysis
2014
Corpus ID: 20543953
2013
2013
Simultaneous analysis of oxybutynin and its active metabolite N-desethyl oxybutynin in human plasma by stable isotope dilution LC-MS/MS to support a bioequivalence study.
Primal Sharma
,
Daxesh P. Patel
,
Mallika Sanyal
,
H. Berawala
,
S. Guttikar
,
P. Shrivastav
Journal of Pharmaceutical and Biomedical Analysis
2013
Corpus ID: 33811653
2009
2009
Protective action of intravesical oxybutynin on bladder ultrastructure in rabbits with detrusor overactivity
H. Yamamoto
,
P. Kawano
,
K. T. Balasteghin
,
C. Padovani
,
J. L. Amaro
International Urogynecology Journal
2009
Corpus ID: 29893240
To evaluate the protective effect of intravesical oxybutynin on the ultrastructure of rabbits with detrusor overactivity (DO…
Expand
2007
2007
Binding activities by propiverine and its N-oxide metabolites of L-type calcium channel antagonist receptors in the rat bladder and brain.
S. Uchida
,
S. Kurosawa
,
+4 authors
S. Yamada
Life Science
2007
Corpus ID: 21457087
2005
2005
267Parenteral oxybutynin: A local anaesthetic effect on bladder C-afferents
K. Laet
,
S. Wachter
,
J. Wyndaele
2005
Corpus ID: 71274243
2002
2002
[Therapeutic effects of intrarectal administration of oxybutynin].
P. Radziszewski
,
A. Borkowski
Wiadomosci lekarskie
2002
Corpus ID: 1648008
OBJECTIVES Oxybutynin is a drug of choice in the treatment of the detrusor instability. However the therapeutic doses given…
Expand
2000
2000
Differences in the effects of urinary incontinence agents S‐oxybutynin and terodiline on cardiac K+ currents and action potentials
S. Jones
,
L. Shuba
,
P. Zhabyeyev
,
J. Mccullough
,
T. Mcdonald
British Journal of Pharmacology
2000
Corpus ID: 25924053
The cardiac electrophysiological effects of S‐oxybutynin, a single‐enantiomer drug under evaluation for the management of urinary…
Expand
1998
1998
Pharmacokinetics and effects of intravesical oxybutynin on the paediatric neurogenic bladder.
P. Åmark
,
S. Eksborg
,
O. Juneskans
,
G. Bussman
,
C. Palm
British Journal of Urology
1998
Corpus ID: 8260656
OBJECTIVE To evaluate the pharmacokinetics of both oxybutynin and its active metabolite, N-desethyl oxybutynin (NDO), when the…
Expand
1996
1996
Effect of food on the bioavailability of oxybutynin from a controlled release tablet
E. Lukkari
,
P. Castrén-Kortekangas
,
A. Juhakoski
,
E. Löyttyniemi
,
K. Aranko
,
P. Neuvonen
European Journal of Clinical Pharmacology
1996
Corpus ID: 11479058
Objective: The effect of food on the bioavailability of oxybutynin was assessed in a randomised cross-over study in 23 healthy…
Expand
1993
1993
Topical effect of intravesical oxybutynin.
W. Bonney
,
R. Robinson
,
R. Theobald
Journal of Urology
1993
Corpus ID: 33969886
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE